Kailera Therapeutics (KLRA US): Synthetic Expert Call Transcript (15 Oct 2026)
Ribupatide (KAI-9531) is positioned for high-BMI weight loss, but global market entry depends on mid-2028 KaiNETIC Phase 3 data: Kailera...
2 Views
Zuckerberg & Wang Wax Lyrical Over Cheeky Pints With Stripe’s Collison
You know, we're going to write this check for like, I don't know, like $100 billion, $200 billion. I'm like, Alex, are you sure this is going to work?
3 Views
HK IPO: Five Red Flags of Demand Rigging
HK IPO: The SFC suspended Cloudbreak and Baicha and froze HK$4.66bn of assets over suspected IPO rigging. From its releases and the deal filings,...
15 Views
[Japan M&A] EQT Raises by ¥1 (+0.0272%) AGAIN. EQT Is STILL Upset with Bain and the Market
EQT has again raised by a single ¥1 tick to counter a bid which is 38 ticks higher and a market price 138 ticks higher. EQT is upset with Bain and...
15 Views
Ingenia (INA AU)'s Soft No As Warburg Adds More Gruel
Ingenia is rolling over. And Peet popping. Arbs unwinding suggests a soft no to Warburg's terms, especially at it relates to abandoning the Peet...
24 Views